Stanley D. Glick
Professor Emeritus
Neuroscience and Experimental Therapeutics
Albany Medical College
United States of America
Biography
Dr. Stanley D. Glick is currently working as a Professor Emeritus in the Department of Neuroscience and Experimental Therapeutics, Albany Medical College , USA. His research interests includes neurobiology of addictive drugs, behavioral (e.g., craving) and physiological (e.g., withdrawal) aspects of addiction and dependence, treating addictive disorders. He is serving as an editorial member and reviewer of several international reputed journals. Dr. Stanley D. Glick is the member of many international affiliations. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to neurobiology of addictive drugs, behavioral (e.g., craving) and physiological (e.g., withdrawal) aspects of addiction and dependence, treating addictive disorders.
Research Interest
neurobiology of addictive drugs, behavioral (e.g., craving) and physiological (e.g., withdrawal) aspects of addiction and dependence, treating addictive disorders
Publications
-
Glick, S.D., Sell, E.M. and Maisonneuve, I.M. Brain regions mediating a3ß4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration. Europ. J. Pharmacol., 2008, 599: 91-95.
-
Glick, S.D., Maisonneuve, I.M., Kitchen, B.A., and Fleck, M.W. Antagonism of alpha3beta4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur. J. Pharmacol. 2002, 438: 99-105.
-
Maisonneuve, I.M. and Glick, S.D. Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment. Pharmacol. Biochem. Behav., 2003, 75: 607-618.
-
Pace, C.J., Glick, S.D., Maisonneuve,I.M., He, L.W., Jokiel, P.A., Kuehne, M.E. and Fleck, M.W. Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration. Europ. J. Pharmacol., 2004, 492: 159-167.
-
Glick, S.D., Ramirez, R.L., Livi, J.M. and Maisonneuve, I.M. 18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats. Europ. J. Pharmacol., 2006, 537:94-98.
